Yahoo Finance BlackRock’s Valuations Stable amid Strong Operating Performance
BlackRock Is Riding High on iShares, Retail, and Products
BlackRock Is Riding High on iShares, Retail, and Products
A rally attempt is underway. Tesla and AI play Vertiv were big earnings winners. Meta and ServiceNow loom tonight.
NEW YORK and VIENNA, Austria, April 24, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that the Company has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application for HB-700, a novel arenaviral therapeutic vaccine for the treatment of KRAS-mutated cancers. HOOKIPA’s HB-700 program is designed
I’ve previously exhibited a total lack of interest in gardening, but this is the year when everything will change
According to a recent analysis of retirement expenses on GOBankingRates, the amount of money you'll need for retirement will vary greatly depending on what state you choose to live in. It can cost you...
Enacted in 1935, Social Security has been one of the most successful programs in U.S. history. Social Security was originally designed to help provide a backstop for Americans suffering from the...
Experts believe that phone-based childhoods are seriously harming mental health — and parents are fighting back, says Emily Phillips
The BPL-003 Phase 2a trial is an open-label study investigating BPL-003 as both monotherapy and adjunctive to SSRIs in patients with Treatment Resistant Depression.Initial results from the recently completed monotherapy Part 1 of the study were shared in March 2024, and showed that a single dose of BPL-003 was safe and well-tolerated, with a rapid and durable antidepressant effect lasting up to 12-weeks post-dose. Part 2 of the study will investigate a single dose of BPL-003 in patients who are
Squamish, BC., April 24, 2024 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer is pleased to announce a memorandum of understanding with Squamish Search and Rescue (SSAR), pursuant to which Draganfly will serve as SSAR’s UAV solutions partner. SSAR is one of the busiest Search and Rescue organizations in Canada serving one of the world's busiest outdoor parks and wild
Program is the Product of a Research Collaboration between Biolojic Design and Nektar entered in 2021TEL AVIV, Israel and SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- Biolojic Design, a biotechnology company that uses AI to transform antibodies into intelligent medicinal solutions, today announced that Nektar exercised its license option to develop a program resulting from the companies’ research collaboration initiated in 2021. The research collaboration was established to design and test
DURHAM, N.C., April 24, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that it will host a live conference call and audio webcast on Wednesday, May 1, 2024 at 8:30 a.m. ET to report financial results for the first quarter ended March 31, 2024, and to provide a business overview. To access the live conference call, please dial (646)
July 5, 2024 payment date following June 10, 2024 record dateTORONTO, April 24, 2024 (GLOBE NEWSWIRE) -- Rogers Communications Inc. (TSX: RCI.A and RCI.B) (NYSE: RCI) (“Rogers”) announced that its Board of Directors declared a quarterly dividend totaling 50 cents per share (the “Quarterly Dividend”) on each of its outstanding Class B Non-Voting shares (“Class B Shares”) and Class A Voting shares. The Quarterly Dividend will be paid on July 5, 2024 to shareholders of record on June 10, 2024. Quar
TEL AVIV, Israel, April 24, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced the company will report its first quarter 2024 financial results and provide a business update on May 9, 2024, at 7:00 am Eastern Time. Investors who would like to discuss the financial results or business update after the earnings release has been
BETHESDA, Md., April 24, 2024--Keep Company Announces First CTO, Zvi Band, and $1.4M Fundraising Round
PHILADELPHIA, April 24, 2024--2024 Talent Experience Award Winners Recognized at IAMPHENOM
SAN FRANCISCO, April 24, 2024--Airwallex, a leading global payments and financial platform for modern businesses, today announced the U.S. launch of its payment acceptance solution. U.S.-based merchants can use the service to accept payments from domestic and international customers. Additionally, foreign merchants with U.S. entities can provide a localized payment experience to their U.S.-based customers, unlocking higher acceptance rates and lower operating costs. Airwallex now supports mercha
Paper highlights findings on impact of a gluten-containing diet on serologic status in celiac diseaseBOCA RATON, Fla., April 24, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced research generated from two previously completed Phase 2 clinical trials of latiglutenase has be
Company to Ship First Commercially Marketed Oil SalesSince Resumption of Operations in February Rig Scheduled for First Exploratory Well on Utah Asset Bakersfield, CA, April 24, 2024 (GLOBE NEWSWIRE) -- Trio Petroleum Corp (NYSE American: “TPET”, “Trio” or the “Company”), a California-based oil and gas company, today provided updates on its petroleum assets in Monterey County, California, and Uintah County, Utah. The Company this week will make its first sale and shipment of oil produced at the
Newly Created Roles Support Continued Global Cannabis GrowthVANCOUVER, British Columbia and ORLANDO, Fla., April 24, 2024 (GLOBE NEWSWIRE) -- Village Farms International, Inc. (“Village Farms” or “the Company”) (NASDAQ: VFF) today announced that it is expanding its executive team with the following new roles: Chief Operating Officer – Ann Gillin Lefever;President, Global Medical Cannabis – Paul Furfaro; and,General Counsel, Global Cannabis – John Harloe. “We have expanded our global cannabis bus
French Data Center Market French Data Center Market Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The "France Data Center Market - Investment Analysis & Growth Opportunity 2024-2029" report has been added to ResearchAndMarkets.com's offering.The French data center market by investment is expected to grow at a CAGR of 4.93% from 2023-2029, from USD 3.3 Billion in 2023 to reach USD 4.4 Billion in 2029. France is leading in digital product leadership in Europe, ahead of Germany and the UK. Nearly half
HIGHLIGHTS Option provides Inspiration Energy an opportunity to acquire a 70% interest in each of ATHA’s early-stage Plateau Property (27,252 Ha) and Ledge Property (37,784 Ha), located in the Athabasca Basin, by fulfilling a total of $8 million in exploration expenditures on the properties: Plateau: Inspiration must incur a total of $3.8 million in eligible exploration expenses between closing of the agreement and September 1, 2028Ledge: Inspiration must incur a total of $4.2 million in eligibl